Clinical Study to Evaluate Antihyperlipidemic Effect of a Classical Unani Antiobesity Formulation

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 128 participants.

Also called NCT01332747

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 128 participants (enrolled count) (from the registry)
Sponsor
Jamia Hamdard University (from the registry)
Registry
  • NCT NCT01332747
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
India (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01332747. Randomized; no masking; primary purpose treatment. Start 2010-05 (registry gives no type); primary completion 2011-05 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Study to Evaluate Antihyperlipidemic Effect of a Classical Unani Antiobesity Formulation
Condition
Hyperlipidemia
Intervention (Drug)
safoof e muhazzil
Intervention (Drug)
compressed tablet of safoof e muhazzil
Intervention (Drug)
Atorvastatin
Lead sponsor
Jamia Hamdard University (class: other)

Record details

Record id
cardio:ct-nct01332747
Content hash
f4c9886be04956455b2efe2b6770f626c1c355f324968829a27071251a8b1a10